File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ajur.2022.02.005
- Scopus: eid_2-s2.0-85141150678
- WOS: WOS:000906894900003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Advances in penile-sparing surgical approaches
Title | Advances in penile-sparing surgical approaches |
---|---|
Authors | |
Keywords | Circumcision Glans resurfacing Glansectomy Laser ablation Mohs micrography Penile cancer Penile-preserving surgery Wide local excision |
Issue Date | 2022 |
Citation | Asian Journal of Urology, 2022, v. 9, n. 4, p. 359-373 How to Cite? |
Abstract | Objective: Penile cancer (PeCa) is a rare disease with a global incidence of 36 068 new cases in 2020. This accounts for 0.4% of all male malignancies. The surgical management of PeCa depends on the location of the tumour and depth of invasion. Here, we review the oncological and functional outcomes of penile-preserving surgery (PPS). Methods: A PubMed search until July 2021 on PPS for PeCa was conducted; a narrative review on different penile-sparing approaches and outcomes was performed. Results: PPS is now the standard of care in specialist centres for distal tumours not involving the corpus cavernosa. Laser therapy, glans resurfacing, and wide local excision are options for superficial lesions, whilst glansectomy is required for lesions invading into the corpus spongiosum. Conclusion: PPS aims to preserve urinary and sexual function without compromising oncological outcomes. |
Persistent Identifier | http://hdl.handle.net/10722/328841 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.658 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pang, Karl H. | - |
dc.contributor.author | Alnajjar, Hussain M. | - |
dc.contributor.author | Muneer, Asif | - |
dc.date.accessioned | 2023-07-22T06:24:32Z | - |
dc.date.available | 2023-07-22T06:24:32Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Asian Journal of Urology, 2022, v. 9, n. 4, p. 359-373 | - |
dc.identifier.issn | 2214-3882 | - |
dc.identifier.uri | http://hdl.handle.net/10722/328841 | - |
dc.description.abstract | Objective: Penile cancer (PeCa) is a rare disease with a global incidence of 36 068 new cases in 2020. This accounts for 0.4% of all male malignancies. The surgical management of PeCa depends on the location of the tumour and depth of invasion. Here, we review the oncological and functional outcomes of penile-preserving surgery (PPS). Methods: A PubMed search until July 2021 on PPS for PeCa was conducted; a narrative review on different penile-sparing approaches and outcomes was performed. Results: PPS is now the standard of care in specialist centres for distal tumours not involving the corpus cavernosa. Laser therapy, glans resurfacing, and wide local excision are options for superficial lesions, whilst glansectomy is required for lesions invading into the corpus spongiosum. Conclusion: PPS aims to preserve urinary and sexual function without compromising oncological outcomes. | - |
dc.language | eng | - |
dc.relation.ispartof | Asian Journal of Urology | - |
dc.subject | Circumcision | - |
dc.subject | Glans resurfacing | - |
dc.subject | Glansectomy | - |
dc.subject | Laser ablation | - |
dc.subject | Mohs micrography | - |
dc.subject | Penile cancer | - |
dc.subject | Penile-preserving surgery | - |
dc.subject | Wide local excision | - |
dc.title | Advances in penile-sparing surgical approaches | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.ajur.2022.02.005 | - |
dc.identifier.scopus | eid_2-s2.0-85141150678 | - |
dc.identifier.volume | 9 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 359 | - |
dc.identifier.epage | 373 | - |
dc.identifier.eissn | 2214-3890 | - |
dc.identifier.isi | WOS:000906894900003 | - |